Fostamatinib and its Impurities

Fostamatinib, sold under the brand names Tavalisse and Tavlesse, is a tyrosine kinase inhibitor medication for the treatment of chronic immune thrombocytopenia. Reference standards of Fostamatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 6 results for Fostamatinib Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 06 2030000

Fostamatinib

Fostamatinib


  • Catalogue No.:PA 06 2030000

  • CAS :

    901119-35-5

  • Molecular Formula : C23H26FN6O9P

  • Molecular Weight : 580.47

Drug Reference Standards & Impurity Synthesis in India
PA 06 2031000

6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one

6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one


  • Catalogue No.:PA 06 2031000

  • CAS :

    841290-80-0

  • Molecular Formula : C22H23FN6O5

  • Molecular Weight : 470.46

Drug Reference Standards & Impurity Synthesis in India
PA STI 089368

Fostamatinib-13C-D3

Fostamatinib-13C-D3


  • Catalogue No.:PA STI 089368

  • CAS :

    NA

  • Molecular Formula : C2213CH23D3FN6O9P

  • Molecular Weight : 584.48

Drug Reference Standards & Impurity Synthesis in India
PA 06 2031001

(6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate

(6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate


  • Catalogue No.:PA 06 2031001

  • CAS :

    NA

  • Molecular Formula : C23H25FN7O10P

  • Molecular Weight : 609.46

Drug Reference Standards & Impurity Synthesis in India
PA 06 2031002

(6-((5-Fluoro-2-(nitroso(3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate

(6-((5-Fluoro-2-(nitroso(3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate


  • Catalogue No.:PA 06 2031002

  • CAS :

    NA

  • Molecular Formula : C23H24FN8O11P

  • Molecular Weight : 638.46

Drug Reference Standards & Impurity Synthesis in India
PA 06 2031003

(6-((5-Fluoro-2-(nitroso(3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate

(6-((5-Fluoro-2-(nitroso(3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate


  • Catalogue No.:PA 06 2031003

  • CAS :

    NA

  • Molecular Formula : C23H25FN7O10P

  • Molecular Weight : 609.46

pharmaffiliates